3 results match your criteria: "Blood and Viral Diseases Research Center[Affiliation]"
Tailored prophylaxis in children with severe hemophilia: A four-year Iranian study.
Transfus Apher Sci
December 2021
Iranian Comprehensive Hemophilia Care Center, Tehran, Iran; Iranian Comprehensive Hemophilia Care Center, Blood and Viral Diseases Research Center, Tehran, Iran. Electronic address:
Background: Prophylaxis the current standard care for patients with severe hemophilia should be planned to optimize the replacement therapy and minimize bleeding. We report our single-center experience of tailored prophylaxis in children affected by hemophilia A (HA) and hemophilia B (HB).
Methods: This study was conducted on 55 patients, under 15 years, with HA (PWHA, n: 46) and HB (PWHB, n: 9) between 2015 and 2019.
Congenital Combined Bleeding Disorders, a Comprehensive Study of a Large Number of Iranian Patients.
Clin Appl Thromb Hemost
October 2021
Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- Congenital combined bleeding disorders (CBDs) are rare and often related to consanguineous marriages, presenting symptoms from minor bleeding to severe complications.
- The study evaluated 450 patients at the Iranian Comprehensive Hemophilia Care Center, identifying FV-FVII deficiency and FVII-FX deficiency as the most prevalent types among the analyzed cases.
- Findings highlighted that a significant number of patients experienced postoperative bleeding, and the majority received on-demand treatment rather than preventative care, indicating a need for better management strategies in Iran.
Inhibitor development in patients with type 3 Von Willebrand disease, a comprehensive study on 99 Iranian patients.
Haemophilia
July 2021
Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.